PostmenopausalPostmenopausalNCT07065526
Application of EFT in Postmenopausal Women
A study testing Emodin in people with Postmenopausal and Sleep, run by KTO Karatay University at 2 sites in Turkey (Türkiye).
Trial summary
Objectives: This study was conducted to determine the effect of emotional liberation technique on sleep and quality of life in postmenopausal women. Methods: The study was conducted as a randomized controlled trial with 58 women in a university hospital in Turkey. Read more about this study
- Who is it for?
- Ages 45 to 60 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Postmenopausal, Sleep, Quality of Life
- What is being tested?
- Emodin
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 58 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 15 Sep 2023to 10 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 60 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Between 45 and 60 years old,
- No menstruation for at least 12 months
- A score of 5 or higher on the Pittsburgh Sleep Quality Index (PSQI)
- Conscious postmenopausal women who can read and write Turkish and have person, place, and time orientation
Who cannot join
- Anyone with an intellectual disability or diagnosed psychiatric illness, anyone taking medications that may affect sleep patterns, anyone on hormone replacement therapy,
- People who have previously been trained in EFT and have communication problems.
Trial locations and contacts
2 sites in 1 country.
Turkey (Türkiye)2 sites
KTO Karatay University
Karatay, Konya, 4200
Necmettin Erbakan Üniveristesi Tıp Fakültesi Hastanesi
Konya, Meram, 42080
About this study
Official title: The Effect of Emotional Freedom Technique Applied to Postmenopausal Women on Sleep and Quality of Life: A Randomized Controlled Study
Objectives: This study was conducted to determine the effect of emotional liberation technique on sleep and quality of life in postmenopausal women.
Methods: The study was conducted as a randomized controlled trial with 58 women in a university hospital in Turkey. Of the women, 29 were in the intervention group and 29 were in the control group. Data were collected using the Personal Information Form, Subjective Experience Unit Scale (SUE), Pittsburg Sleep Quality Index (PSQI) and Menopause Specific Quality of Life Scale (MENQOL). EFT was applied to women in the intervention group four times at one-week intervals. The emotional liberation technique was applied to the women in the control group after the post-test was applied and the data were reported.
- Conditions
- Postmenopausal, Sleep, Quality of Life
- Being tested
- Emodin
- Keywords
- quality of life, Emotional freedom technique, postmenopausal women, sleep quality
- Medical subject headings
- Sleep Initiation and Maintenance Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EmodinBehavioural
Following the pre-test in the first encounter, the participants were administered the first EFT lasting 30-40 minutes by the first author, who is a certified EFT facilitator, followed by the CPS. Afterwards, a total of 4 sessions of EFT were administered at 1-week intervals. The CPS was applied before and after each EFT. After the last EFT session, SUE, PSQI and MENQOL post-tests were administered.
| Study group | Role | What they receive |
|---|---|---|
| EFT Group | Experimental | Following the pre-test in the first encounter, the participants were administered the first EFT lasting 30-40 minutes by the first author, who is a certified EFT facilitator, followed by the CPS. Afterwards, a total of 4 sessions of EFT were administered at 1-week intervals. The CPS was applied before and after each EFT. After the last EFT session, SUE, PSQI and MENQOL post-tests were administered. Receives: Behavioral: Emodin |
| Control group | No intervention | Following the pre-test application, post-tests were applied 4 weeks later. They received routine treatment and care. The control group was taught EFT application after the study was completed. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sleep quality
The emotional freedom technique was applied four times a week.These results are evaluated using the Pittsburgh Sleep Quality Index. A total scale score of 5 or above is considered poor sleep.The higher the score on the scale, the lower the sleep quality.
Measured: 1 Month Follow-up
Secondary outcomes (1)
Menopause-Specific Quality of Life
The emotional freedom technique was applied four times a week. These results were evaluated using the Menopause-Specific Quality of Life Questionnaire. The lowest possible score on the scale is 0 and the highest is 154. As the score on the scale increases, the severity of the symptoms increases and quality of life decreases.
Measured: 1 Month Follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jul 2025
- Study start15 Sep 2023
- Primary completion15 Jan 2024
- Study completion10 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PostmenopausalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 58 participants (actual)
Sponsor and investigators
- Lead sponsor
- KTO Karatay University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Merve Yazar, KTO Karatay University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07065526
- Sponsor's protocol ID
- KTO Karatay University
- Acronym
- Postmenopausal
- Status last verified
- Jul 2025
- First submitted
- 12 Nov 2024
- Last updated
- 15 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Emotional Freedom Technique Applied to Postmenopausal Women on Sleep and Quality of Life: A Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT07065526
- Acronym / sponsor ID
- Postmenopausal / KTO Karatay University
- Conditions
- Postmenopausal, Sleep, Quality of Life
- Keywords
- quality of life, Emotional freedom technique, postmenopausal women, sleep quality
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 58 participants (actual)
- Lead sponsor
- KTO Karatay UniversityUniversity, hospital or other
- Study start
- 15 Sep 2023 (actual)
- Primary completion
- 15 Jan 2024 (actual)
- Study completion
- 10 Sep 2024 (actual)
- First posted
- 15 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objectives: This study was conducted to determine the effect of emotional liberation technique on sleep and quality of life in postmenopausal women.
Methods: The study was conducted as a randomized controlled trial with 58 women in a university hospital in Turkey. Of the women, 29 were in the intervention group and 29 were in the control group. Data were collected using the Personal Information Form, Subjective Experience Unit Scale (SUE), Pittsburg Sleep Quality Index (PSQI) and Menopause Specific Quality of Life Scale (MENQOL). EFT was applied to women in the intervention group four times at one-week intervals. The emotional liberation technique was applied to the women in the control group after the post-test was applied and the data were reported.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| EFT Group | Experimental | Behavioral: EmodinFollowing the pre-test in the first encounter, the participants were administered the first EFT lasting 30-40 minutes by the first author, who is a certified EFT facilitator, followed by the CPS. Afterwards, a total of 4 sessions of EFT were administered at 1-week intervals. The CPS was applied before and after each EFT. After the last EFT session, SUE, PSQI and MENQOL post-tests were administered. |
| Control group | No intervention | –Following the pre-test application, post-tests were applied 4 weeks later. They received routine treatment and care. The control group was taught EFT application after the study was completed. |
Who may qualify
- Ages
- 45 to 60 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Between 45 and 60 years old,
- No menstruation for at least 12 months
- A score of 5 or higher on the Pittsburgh Sleep Quality Index (PSQI)
- Conscious postmenopausal women who can read and write Turkish and have person, place, and time orientation
Key exclusion criteria (2 listed)
- Anyone with an intellectual disability or diagnosed psychiatric illness, anyone taking medications that may affect sleep patterns, anyone on hormone replacement therapy,
- People who have previously been trained in EFT and have communication problems.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EmodinFollowing the pre-test in the first encounter, the participants were administered the first EFT lasting 30-40 minutes by the first author, who is a certified EFT facilitator, followed by the CPS. Afterwards, a total of 4 sessions of EFT were administered at 1-week intervals. The CPS was applied before and after each EFT. After the last EFT session, SUE, PSQI and MENQOL post-tests were administered. | Behavioural | EFT Group |
Primary outcome
Sleep quality
Time frame: 1 Month Follow-up
The emotional freedom technique was applied four times a week.These results are evaluated using the Pittsburgh Sleep Quality Index. A total scale score of 5 or above is considered poor sleep.The higher the score on the scale, the lower the sleep quality.
1 secondary outcome
Menopause-Specific Quality of Life
Time frame: 1 Month Follow-up
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Postmenopausal
RecruitingPhase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Recruiting
Methylation Profiling in Self-samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Active, not recruitingPhase 1/2
Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause
Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
Recruiting
The Impact of Overnight Active Temperature Regulation on the Gut Microbiome, Inflammation, and Circadian Rhythm.
Poor Sleep Quality, Gut Microbiome
Not yet recruiting
A Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Health, Comfort, and Quality of Life in Postmenopausal Women
Relieves Vaginal Dryness / Improves Self-Lubrication, Improves Strength & Elasticity of Vagina (Aka Collagen and Elastin)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Emodin in people with Postmenopausal and Sleep, run by KTO Karatay University at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sleep quality (time frame: 1 Month Follow-up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2025.